Vancouver, British Columbia – October 07, 2025 – TheNewswire - Pangea Natural Foods Inc. (CSE: PNGA) (OTC: PNGAF) (“Pangea” or the “Company”), is pleased to provide an update on recent business activities and developments, including the launch, through its wholly owned subsidiary Amino Innovations, of its portfolio of peptide products and needle-less delivery system development.

 

Peptide Market and Product Portfolio

In the Q2-2025, Pangea completed its acquisition of Amino Innovations Corp., an innovative health and wellness company delivering non-injectable peptide therapies. The peptide products are designed for specific indications including muscle and joint recovery, longevity, immune support, skin health, sleep, and stress management without the need for prescriptions or injections.

The global peptide therapeutics market was estimated at USD$117.26 billion in 2024 and is projected to reach USD$260.25 billion by 2030, growing at a CAGR of 10.77% from 2025 to 2030.  In 2024 the North America peptide therapeutics market maintained a leading market position with 60.21% of the global market share.  The U.S. dominates the North America peptide therapeutics market due to strong biopharma investments, high research and development spending, and early regulatory approvals.  Based on application, the pain segment is expected to exhibit significant growth in the market between 2025 and 2030.  Based on route of administration, the parenteral (administered or occurring elsewhere in the body than the mouth) segment accounted for the largest revenue share of 84.08% in 2024.  (Source: Grand View Research, Peptide Therapeutics Market 2025-2030)

 

Digital Channels and Early Metrics

Amino Innovations launched its eCommerce platform in June 2025 to enable product education, direct-to-consumer fulfillment, and conversion-optimized purchasing. Early influencer and clinic partner seeding campaigns are underway, with the first wave of user-generated content and testimonials scheduled to go live in September. Strategic marketing partners have been engaged to scale native advertising and performance-based social acquisition. The Company is actively tracking subscription opt-in rates, customer acquisition costs and early cohort behavior to optimize for long-term customer lifetime value.

Initial beta testing determined the top performing products as:

• BPC: a peptide that supports muscle recovery, joint health, and gut balance. 

• KPV: a peptide that promotes immune function and regulates inflammation. 

• BLUE: a nootropic with methylene blue that enhances focus, clarity, and sustained energy. 

All SKUs are available for order at: www.aminoinnovations.com.

Novel Peptide Delivery Systems Pipeline

Amino is advancing the development of patch and sublingual delivery systems that could offer additional needle free options with high compliance and clinical grade absorption potential. A working patch prototype was completed in August.  During Q4-25 the Company will partner with third party laboratories to test for bioavailability and efficacy.

 

Manufacturing

All of the Company’s products are manufactured in the United States at a cGMP-certified facility, adhering to rigorous standards for cleanliness, consistency, and quality. Select products undergo quantitative third-party studies to measure attributes such as stability and potency. This scientific approach reinforces the Company’s commitment to data-driven formulation and transparent product development.

 

New Website and Corporate Materials

To better reflect Pangea’s mission in health and wellness following the acquisition of Amino Innovations, the Company has launched its new website and corporate materials. These materials highlight the Company’s focus on innovative, clean label products and a growing portfolio of nutritional based supplements, peptides, and personal care products. The Company believes the refreshed materials will better resonate with the investor community. Please view the new website and corporate materials at pangeafood.com.

 

About Pangea Natural Foods Inc.

Pangea Natural Foods Inc. is a North American manufacturer specializing in clean-label foods and innovative wellness products. Through its subsidiary Amino Innovations, the Company offers advanced, needle-free peptide therapies that support recovery, cognitive function, and overall health.

 

On Behalf of the Board of Directors

"Pratap Sandhu"

Pratap Sandhu
CEO, Corporate Secretary and Director

+1 (604) 765-8069

Forward-Looking Information

This news release contains forward–looking statements and forward–looking information within the meaning of applicable securities laws. These statements relate to future events or future performance. All statements other than statements of historical fact may be forward–looking statements or information. The forward–looking statements and information are based on certain key expectations and assumptions made by the management of the Company. As a result, there can be no assurance that the acquisition or related matters will be completed as proposed or at all. Although management of the Company believes that the expectations and assumptions on which such forward-looking statements and information are based are reasonable, undue reliance should not be placed on the forward–looking statements and information since no assurance can be given that they will prove to be correct.

Forward-looking statements and information are provided for the purpose of providing information about the current expectations and plans of management of the Company relating to the future. Readers are cautioned that reliance on such statements and information may not be appropriate for other purposes, such as making investment decisions. Since forward–looking statements and information address future events and conditions, by their very nature they involve inherent risks and uncertainties. Actual results could differ materially from those currently anticipated due to a number of factors and risks. These include, but are not limited to, the ability of the Company to complete its planned future activities and anticipated business plans. Other factors may also adversely affect the future results or performance of the Company, including general economic, market or business conditions, changes in the financial markets and changes in laws, regulations and policies affecting the Company's operations and the Company's limited operating history. Accordingly, readers should not place undue reliance on the forward–looking statements and information contained in this news release. Readers are cautioned that the foregoing list of factors is not exhaustive. The forward– looking statements and information contained in this news release are made as of the date hereof and no undertaking is given to update publicly or revise any forward–looking statements or information, whether as a result of new information, future events or otherwise, unless so required by applicable securities laws. The forward-looking statements or information contained in this news release are expressly qualified by this cautionary statement.